(Total Views: 418)
Posted On: 09/09/2019 2:27:41 PM
Post# of 154853
Yes, it sounded like a little delay in BLA submission due to a new FDA request.
But it also sounded as if the approval will be sooner than normal, helping us to get revenues in Q2 2020.
Anything will be possible from now on. Perhaps other BP’s waking up because of the non binding HIV agreement signed.
And NP’s expectation of getting human data on cancer trials soon. If those confirm the preclinical studies, every BP will be fighting for us.
Great buy BTW! Nice entry point (?). GL.
I just had to add today.
But it also sounded as if the approval will be sooner than normal, helping us to get revenues in Q2 2020.
Anything will be possible from now on. Perhaps other BP’s waking up because of the non binding HIV agreement signed.
And NP’s expectation of getting human data on cancer trials soon. If those confirm the preclinical studies, every BP will be fighting for us.
Great buy BTW! Nice entry point (?). GL.
I just had to add today.
(1)
(0)
